V
Vericel Corp D
D
VCEL
37.480
USD
0.09
(0.24%)
قبل الجلسة
حجم التداول
100
الربح لكل سهم
0
العائد الربحي
-
P/E
144
حجم السوق
1,895,514,494
الأخبار المقالات
العنوان: Vericel Corp
القطاع: Healthcare
الصناعة: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.